MX2024009289A - Metodos y composiciones para estabilizar la glucosa en sangre - Google Patents
Metodos y composiciones para estabilizar la glucosa en sangreInfo
- Publication number
- MX2024009289A MX2024009289A MX2024009289A MX2024009289A MX2024009289A MX 2024009289 A MX2024009289 A MX 2024009289A MX 2024009289 A MX2024009289 A MX 2024009289A MX 2024009289 A MX2024009289 A MX 2024009289A MX 2024009289 A MX2024009289 A MX 2024009289A
- Authority
- MX
- Mexico
- Prior art keywords
- blood glucose
- compositions
- methods
- stabilizing blood
- stabilizing
- Prior art date
Links
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title abstract 3
- 239000008280 blood Substances 0.000 title abstract 3
- 210000004369 blood Anatomy 0.000 title abstract 3
- 239000008103 glucose Substances 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000000087 stabilizing effect Effects 0.000 title 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000002641 glycemic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21014—Microbial serine proteases (3.4.21.14)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263303112P | 2022-01-26 | 2022-01-26 | |
| PCT/US2023/061253 WO2023147350A1 (en) | 2022-01-26 | 2023-01-25 | Blood glucose stabilizing methods and compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024009289A true MX2024009289A (es) | 2025-01-09 |
Family
ID=87472642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024009289A MX2024009289A (es) | 2022-01-26 | 2024-07-26 | Metodos y composiciones para estabilizar la glucosa en sangre |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US11821013B2 (https=) |
| EP (1) | EP4469075A4 (https=) |
| JP (1) | JP2025504049A (https=) |
| KR (1) | KR20250008727A (https=) |
| AU (2) | AU2023213894B2 (https=) |
| CA (1) | CA3250056A1 (https=) |
| MX (1) | MX2024009289A (https=) |
| WO (1) | WO2023147350A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4469075A4 (en) | 2022-01-26 | 2025-09-10 | Digestiva Inc | METHODS AND COMPOSITIONS FOR STABILIZING BLOOD GLUCOSE |
| EP4709834A1 (en) * | 2023-05-11 | 2026-03-18 | Digestiva, Inc. | Wine dehazing methods and compositions |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3097145A (en) | 1962-03-30 | 1963-07-09 | Takeda Chemical Industries Ltd | Acid protease and the production thereof |
| JPH05244957A (ja) | 1991-10-04 | 1993-09-24 | Suntory Ltd | シュードモナス属細菌由来ペプスタチン非感受性酸性プロテアーゼ遺伝子 |
| US6302685B1 (en) | 1997-09-16 | 2001-10-16 | University Of Medicine And Dentistry Of New Jersey | Human lysosomal protein and methods of its use |
| JP2002078489A (ja) | 2000-09-04 | 2002-03-19 | Daiwa Kasei Kk | セリン残基が活性発現に関与する新規酸性プロテアーゼ |
| US20040142325A1 (en) | 2001-09-14 | 2004-07-22 | Liat Mintz | Methods and systems for annotating biomolecular sequences |
| US7320788B2 (en) | 2002-02-14 | 2008-01-22 | The Board Of Trustees Of The Leland Stanford Junior University | Enzyme treatment of foodstuffs for Celiac Sprue |
| EP1685764A1 (en) | 2005-01-27 | 2006-08-02 | Globus Egg Sciences B.V. | Anti-hypertensive functional food products |
| RU2446210C2 (ru) | 2006-02-02 | 2012-03-27 | ДСМ АйПи АССЕТС Б.В. | Пищевой продукт, содержащий специфичную к пролину протеазу, способ его производства и его применение для расщепления токсичных или аллергенных пептидов глютена |
| CN101455368B (zh) | 2008-12-29 | 2012-06-27 | 陕西天宝大豆食品技术研究所 | 杏仁肽营养品及其制备方法 |
| WO2011125015A2 (en) | 2010-04-05 | 2011-10-13 | Bar-Ilan University | Protease-activatable pore-forming polypeptides |
| US20130034530A1 (en) | 2011-04-29 | 2013-02-07 | David R. Fantz | Dietary Supplement Cognitive Support System |
| CA2882502A1 (en) | 2011-08-10 | 2013-02-14 | University Of Washington Through Its Center For Commercialization | Compositions and methods for treating celiac sprue disease |
| US20130156884A1 (en) | 2011-12-19 | 2013-06-20 | Triarco Industries | Protease enzymes for increased protein digestion rate and absorption and methods of using the same |
| AU2013311668B2 (en) * | 2012-09-05 | 2019-02-28 | Novozymes A/S | Polypeptides having protease activity |
| US10266815B2 (en) | 2013-08-14 | 2019-04-23 | University Of Washington Through Its Center For Commercialization | Compositions and methods for treating celiac sprue disease |
| CN106191183B (zh) | 2015-05-04 | 2019-11-29 | 浙江海正药业股份有限公司 | 西兰花蛋白肽的制备方法及其应用 |
| BE1023038B1 (fr) | 2015-06-12 | 2016-11-09 | Proteifood Sa | Produit alimentaire expanse sec a base de proteine et son procede de fabrication |
| CA3013383A1 (en) * | 2016-02-25 | 2017-08-31 | Dupont Nutrition Biosciences Aps | Method for producing a protein hydrolysate employing an aspergillus fumigatus tripeptidyl peptidase |
| ES3039968T3 (en) * | 2016-06-23 | 2025-10-28 | Ew Nutrition Gmbh | Feed composition comprising an acid protease |
| AU2017380106B2 (en) | 2016-12-22 | 2024-05-09 | Ew Nutrition Gmbh | Stable protease variants |
| WO2020087017A1 (en) * | 2018-10-26 | 2020-04-30 | The Regents Of The University Of California | Use of proteolytic enzymes to enhance protein bioavailability |
| EP4469075A4 (en) | 2022-01-26 | 2025-09-10 | Digestiva Inc | METHODS AND COMPOSITIONS FOR STABILIZING BLOOD GLUCOSE |
-
2023
- 2023-01-25 EP EP23747806.0A patent/EP4469075A4/en active Pending
- 2023-01-25 KR KR1020247027802A patent/KR20250008727A/ko active Pending
- 2023-01-25 CA CA3250056A patent/CA3250056A1/en active Pending
- 2023-01-25 WO PCT/US2023/061253 patent/WO2023147350A1/en not_active Ceased
- 2023-01-25 JP JP2024545047A patent/JP2025504049A/ja active Pending
- 2023-01-25 AU AU2023213894A patent/AU2023213894B2/en active Active
- 2023-03-15 US US18/184,476 patent/US11821013B2/en active Active
- 2023-10-10 US US18/484,305 patent/US20240117333A1/en not_active Abandoned
- 2023-12-12 US US18/537,715 patent/US12516306B2/en active Active
-
2024
- 2024-07-26 MX MX2024009289A patent/MX2024009289A/es unknown
-
2025
- 2025-07-09 AU AU2025205298A patent/AU2025205298A1/en active Pending
- 2025-12-13 US US19/418,964 patent/US20260103698A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240124864A1 (en) | 2024-04-18 |
| CN119136820A (zh) | 2024-12-13 |
| JP2025504049A (ja) | 2025-02-06 |
| AU2023213894B2 (en) | 2025-04-10 |
| US12516306B2 (en) | 2026-01-06 |
| WO2023147350A1 (en) | 2023-08-03 |
| AU2023213894A1 (en) | 2024-08-15 |
| EP4469075A4 (en) | 2025-09-10 |
| US11821013B2 (en) | 2023-11-21 |
| KR20250008727A (ko) | 2025-01-15 |
| US20240117333A1 (en) | 2024-04-11 |
| AU2025205298A1 (en) | 2025-07-31 |
| CA3250056A1 (en) | 2023-08-03 |
| US20260103698A1 (en) | 2026-04-16 |
| EP4469075A1 (en) | 2024-12-04 |
| US20230257729A1 (en) | 2023-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024009289A (es) | Metodos y composiciones para estabilizar la glucosa en sangre | |
| BR112021021295A2 (pt) | Proteínas recombinantes do leite e composições compreendendo as mesmas | |
| CO2021005231A2 (es) | Composiciones y métodos para la edición génica de lactato deshidrogenasa (ldha) | |
| BR112022009216A2 (pt) | Métodos e composições para tratar um distúrbio associado a angiotensinogênio (agt) | |
| BR112022015380A2 (pt) | Composições e métodos para edição de gene de calicreína (klkb1) | |
| ECSP066326A (es) | Derivados sustituidos del dióxido de tiazol-benzoisotiazol, método para su producción y uso de los mismos | |
| EA032918B1 (ru) | Съедобная композиция ресвератрола и моноглюкозида флавоноида для снижения постпрандиальной пиковой амплитуды уровня глюкозы в крови или гликемической реакции | |
| TR201808369A2 (tr) | Sivi yumurtanin ultrases tekni̇ği̇yle i̇şlenmesi̇ yöntemi̇ | |
| WO2020185541A3 (en) | Zilucoplan as deep tissue penetrating c5 inhibitor | |
| EP3838193C0 (en) | CATHETER WITH GUIDED, MOVEABLE CUTTING DEVICE FOR ACTIVE CUTTING/INCISION | |
| MX2020006005A (es) | Copolimeros bloque anfifilicos, micelas y metodos para tratar o prevenir insuficiencia cardiaca. | |
| WO2019159051A3 (en) | Using thermochromic ink for blood simulation in medical training | |
| BR112022020992A2 (pt) | Dispositivo médico que compreende uma matriz biológica acelular e pelo menos um polímero | |
| WO2023230534A3 (en) | Use of fusion constructs for il-2 independent t cell therapy | |
| Achal et al. | Anterolateral thigh skinfold thickness and the European head and neck cancer patient: a prospective study | |
| MX386106B (es) | Composiciones de alimento para mascotas. | |
| PY2150987A (es) | Novedoso procedimiento de medición de la actividad enzimática | |
| ATE439854T1 (de) | Proteinhydrolysat mit antidiabetischer wirkung | |
| BR112022013252A2 (pt) | Lanche macio assado e métodos de fazer | |
| EP3932202A3 (en) | Antimicrobial material, especially packaging material, method of obtaining the antimicrobial material and application thereof | |
| UA145318U (uk) | Сік березовий з цукром та імбиром | |
| BR112022011207A2 (pt) | Composições para cuidados pessoais e métodos para estas | |
| UA145317U (uk) | Сік березовий з імбиром | |
| DE10345401A1 (de) | Verwendung von alpha-Linolensäure und alpha-linolensäurehaltigen Pflanzenölen | |
| BR112021023101A2 (pt) | Método para expansão de células-tronco adultas do sangue total |